In Episode 3, you will discover Cellectis’ innovation cycle, ‘from bench to bed’; how a new innovative project takes form, is developed and ends up in a patient.
Join us on a virtual visit to all Cellectis sites (New York, Raleigh and Paris) featuring a virtual tour of our newly finished GMP manufacturing facilities. Cellectis scientists will provide an inside look into the Company’s earliest-stage, preclinical product candidate pipeline and gene-editing technologies, showing our audience our best-in-class proprietary technologies, within a “one-stop-shop.”
